Canadian Lyme Disease Research Network

The Canadian Institutes of Health Research (CIHR), under the scientific leadership of the Institute of Infection and Immunity (III), and the Institute of Musculoskeletal Health and Arthritis (IMHA) in partnership with the Public Health Agency of Canada (PHAC), have funded the Canadian Lyme Disease Research Network.

The funding is expected to:

1. Build a national network on Lyme disease to facilitate and support national collaboration among Lyme disease stakeholders (researchers, clinicians, and patients) in resource and knowledge sharing:
   • Mobilize, strengthen and build capacity in the Lyme disease research community.
   • Develop innovative multidisciplinary curricula and training opportunities for students and professionals.
   • Facilitate and support translation and dissemination of new knowledge from bench to bedside to population in order to:
     • improve clinical science and practice;
     • foster policy changes, leading to transformative and measurable improvements in the development and implementation of evidence-informed practices, policies, services, products and programs;
     • improve patient outcomes, access to care and quality, efficiency and effectiveness of health care.
2. Develop a national cohort of patients in order to understand the association between serological and clinical phenomenology of Lyme disease on a longitudinal basis (including a biobank creation and maintenance).

The four-year (2018–2022) grant has been awarded to the following successful applicants:

Team Grant: Research Network on Lyme Disease

Funding for this network commenced on September 2018 and will run through August 2022.

For more information on the successful team, please visit the Research Network on Lyme Disease Funding Decision Page or the official website of the Canadian Lyme Disease Research Network.

Date modified:

2023-05-03